RAFFA WEALTH MANAGEMENT, LLC’s Emergent Biosolutions EBS Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12	Closed	-$394	–	508
2016 Q4	$394	Hold	12	–	–	﹤0.01%	826
2016 Q3	$378	Hold	12	–	–	﹤0.01%	811
2016 Q2	$337	Sell	12 -4	-25%	-$157	﹤0.01%	814
2016 Q1	$582	Hold	16	–	–	﹤0.01%	626
2015 Q4	$640	Hold	16	–	–	﹤0.01%	563
2015 Q3	$456	Hold	16	–	–	﹤0.01%	704
2015 Q2	$527	Sell	16 -4	-20%	-$124	﹤0.01%	684
2015 Q1	$575	Hold	20	–	–	﹤0.01%	638
2014 Q4	$545	Hold	20	–	–	﹤0.01%	634
2014 Q3	$426	Buy	+20	New	+$458	﹤0.01%	728
2014 Q1	–	Sell	-20	Closed	-$545	–	410
2013 Q4	$545	Buy	+20	New	+$417	﹤0.01%	634

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's EBS Position: Q1 2017 in Review

RAFFA WEALTH MANAGEMENT, LLC sold out of Emergent Biosolutions (EBS) in Q1 2017, closing a stake of 12 shares — an estimated $394 sold.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in EBS in Q4 2013 and held it in 11 quarters. The position peaked at $640 in Q4 2015. 176 funds tracked by Wall St. Rank hold EBS as of Q1 2017.

RAFFA WEALTH MANAGEMENT, LLC reported no remaining Emergent Biosolutions position as of Q1 2017 after selling out during the quarter.
RAFFA WEALTH MANAGEMENT, LLC sold 12 Emergent Biosolutions shares in Q1 2017, an estimated $394.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Emergent Biosolutions in Q4 2013 and held it in 11 quarters.
RAFFA WEALTH MANAGEMENT, LLC's Emergent Biosolutions position peaked at $640 in Q4 2015.
176 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2017.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q1 2017, filed 27 Jul 2026.